FindTrial
Sign In

A non randomized control trial regarding efficacy of single injection 25% of dextrose and o.5% of bupivacaine for myofascial pain syndrome

Efficacy of single injection prolotherapy in myofascial pain- non randomized controlled trail

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/029916
Enrollment
30
Registered
2020-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M628- Other specified disorders of muscle

Interventions

Intervention1: 25% dextrose with 0.5 % bupivacaine: A mixture of 1ml0.5% bupivacaine with 1 ml of 25% dextrose for each trigger point is injected at time of presentation alongwith rhomboid strengthene

Sponsors

Amrita Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: with pain scores > 6 assessed by visual analgue score

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
VAS, EQ5DL5Timepoint: pre injection post injection ,one month—

Secondary

MeasureTime frame
EQ5DL5, number of trigger pointsTimepoint: pre injection post injection ,one month—

Countries

India

Contacts

Public ContactRavi Sankaran

Amrita Institute of Medical Sciences

niravjoshi7200@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026